# Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®

> **NCT02549573** · PHASE4 · TERMINATED · sponsor: **MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals** · enrollment: 13 (actual)

## Conditions studied

- Parkinson's Disease
- Motor Symptoms

## Interventions

- **DRUG:** APOKYN
- **BEHAVIORAL:** Physical Therapy

## Key facts

- **NCT ID:** NCT02549573
- **Lead sponsor:** MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-01
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Subject enrollment is unsatisfactory
- **Last updated:** 2023-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02549573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02549573, "Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02549573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*